|
Breast cancer: Endomagnetics receives IDE approval to initiate US trials
Cancer healthcare company Endomagnetics has announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to initiate a...
More... |
| All times are GMT -7. The time now is 01:34 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021